Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 13 Jan 2020
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Stephen Padilla, 6 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).

Pharmacist assessment needed to prevent inappropriate medications in elderly cancer patients

14 Aug 2019

Current prescribing practices in elderly patients with cancer can be optimized if clinical pharmacists will evaluate potentially inappropriate medications, suggests a recent study.

A total of 114 cancer patients (mean age, 71.78 years; 55.26 percent male) were included. Hypertension and diabetes were the most common concurrent diseases, occurring in 45 (39.47 percent) and 26 (22.81 percent) patients, respectively.

Of the patients, 94.73 percent had polypharmacy, receiving at least five medications. According to the Screening Tool of Older Person’s Prescriptions criteria, 18 patients (17.79 percent) used their medications inappropriately. Furthermore, 112 patients (98.25 percent) had medication omissions according to the Screening Tool to Alert doctors to Right Treatment criteria.

In an earlier study involving 1,329 patients in one region in southern Ireland, results showed that potentially inappropriate drug prescribing and errors of medication omission were highly prevalent among older people living in the community. [Br J Clin Pharmacol 2009;68:936-947]

Another study found an increase in the number of potentially inappropriate medications globally during hospitalization, with a statistical analysis showing that the comorbidity affected the level of inappropriate prescriptions. It further suggested for clinicians to make use of specific tools to guide them towards a more rational use of medicines and reduce probable multidrug-related complications. [Int J Clin Pharm 2016;38:462-468]

The current study assessed potentially inappropriate medication use in elderly patients with cancer at an outpatient oncology clinic from December 2014 to March 2015. Potentially inappropriate medication in this cohort was identified using the Screening Tool of Older Person's Prescriptions/Screening Tool to Alert doctors to Right Treatment criteria.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 13 Jan 2020
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Stephen Padilla, 6 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).